1-9 of 9
Craig Portell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic vulnerability of aggressive B-cell lymphoma to combined MCL-1 inhibition and CAR-T cell therapy

Free
Jing Gao, Xiaohong Zhao, Qing Yin, Allen Hu, Kevin Qiu, Loryn Blackburn, Lenny Lei, Rui Xiong, Jeffrey Craig, Craig Portell, Marco Davila, Andy Bi, Michael Williams, Jianguo Tao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7083.
https://doi.org/10.1182/blood-2025-7083
Published: 2025
Journal Articles

Therapeutic resistance in aggressive B-cell lymphoma is overcome through the reciprocal enhanced efficacy by CDK9 inhibitors and CAR-T cells

Free
Allen Hu, Qing Yin, Michelle Wang, Jing Gao, Kevin Qiu, Loryn Blackburn, Lenny Lei, Rui Xiong, Jeffrey Craig, Craig Portell, Bijal Shah, Michael Williams, Jianguo Tao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7080.
https://doi.org/10.1182/blood-2025-7080
Published: 2025
Journal Articles

Overcoming therapy resistance with multi-targeted CAR-T cells secreting bispecific antibody (BsAb) for the treatment of B-cell malignancies

Free
Qing Yin, Jing Gao, Xiangao Huang, Allen Hu, Rui Xiong, Loryn Blackburn, Jeffrey Craig, Craig Portell, Selina Chen-Kiang, Michael Williams, Jianguo Tao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7263.
https://doi.org/10.1182/blood-2025-7263
Published: 2025
Journal Articles

Final results from the embolden trial:  pembrolizumab in combination with decitabine and pralatrexate in heavily pretreated patients with peripheral and cutaneous T-cell lymphoma

Free
Nathan Roberts, John Lister, N. Nora Bennani, Salvia Jain, Tammy Battaglia, Marian Abdelmalek, Bethany Horton, Emily Ayers, Craig Portell, Thomas Cropley, Prem Batchala, Ipsita Pal, John Manavalan, Owen O'Conner, Enrica Marchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 5417.
https://doi.org/10.1182/blood-2025-5417
Published: 2025
Journal Articles

Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 <1% expression

Free
Grzegorz Nowakowski, Rebecca King, Daniel Kearney, Nancy Bartlett, Jeong-A Kim, Isabelle Fleury, Luigina Mollica, Craig Portell, Christopher Yasenchak, Keenan Fenton, Christopher Hale, Diana Hubbard, Hailing Lu, Monica Patterson, Michelle Fanale, Evelyn Rustia, Uwe Hahn
Journal: Blood
Blood (2025) 146 (Supplement 1): 1905.
https://doi.org/10.1182/blood-2025-1905
Published: 2025
Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Free
Paolo Lopedote, Adrienne Nedved, Lu Chen, Marcus Watkins, Arian Roua, Muhamad Alhaj Moustafa, Seyi Abidoye, Yun Choi, Georgios Pongas, Tony Zhuang, Jean Clement, Megan Searssmith, Laura Sun, Hannah Willis, Brad Kahl, David Bond, Javier Munoz, Izidore S. Lossos, Craig Portell, Michael Wang, Nilanjan Ghosh, Jonathon Cohen, Peter Martin, Jeremy Abramson, Anne Beaven, Patrick Reagan, Daniel Ermann, Taylor Brooks, Ashlee Joseph, Nazila Shafagati, Daniel McLoughlin, Kira Rosenlind, Brian Hill, Nina Wagner-Johnston, Anita Kumar, Umar Farooq, Reem Karmali, Tanaya Shree, Matthew Lunning, Stacy Pak, Alexey Danilov, Yucai Wang, Tycel Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 5351.
https://doi.org/10.1182/blood-2025-5351
Published: 2025
Journal Articles

Phase II study of bendamustine, rituximab, and venetoclax (BR-VEN) for the front-line treatment of Mantle Cell Lymphoma (MCL) in patients ≥60 years old; Updated survival and minimal residual disease (MRD) analysis of precog PrE0405

Free
Craig Portell, Opeyemi Jegede, N. Nora Bennani, Seema Naik, Christopher Reynolds, Priyank Patel, Michael Robertson, Brad Kahl
Journal: Blood
Blood (2025) 146 (Supplement 1): 3574.
https://doi.org/10.1182/blood-2025-3574
Published: 2025
Journal Articles

Postibrutinib outcomes in patients with mantle cell lymphoma

Free
Clinical Trials & Observations
Peter Martin, Kami Maddocks, John P. Leonard, Jia Ruan, Andre Goy, Nina Wagner-Johnston, Simon Rule, Ranjana Advani, David Iberri, Tycel Phillips, Stephen Spurgeon, Eliana Kozin, Katherine Noto, Zhengming Chen, Wojciech Jurczak, Rebecca Auer, Ewa Chmielowska, Stephan Stilgenbauer, Johannes Bloehdorn, Craig Portell, Michael E. Williams, Martin Dreyling, Paul M. Barr, Selina Chen-Kiang, Maurizio DiLiberto, Richard R. Furman, Kristie A. Blum
Journal: Blood
Blood (2016) 127 (12): 1559–1563.
https://doi.org/10.1182/blood-2015-10-673145
Published: 2016
Journal Articles

Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder

Free
Craig Portell, Sucha Nand
Journal: Blood
Blood (2008) 111 (8): 4416–4417.
https://doi.org/10.1182/blood-2008-01-132167
Published: 2008